Trends and Antimicrobial Susceptibilities of Clinical Methicillin-Resistant Staphylococcus aureus Isolates in Fukuoka University Chikushi Hospital 2008-2012
| Autor: | Motoyasu, Miyazaki, Nobuhiko, Nagata, Koichi, Matsuo, Tohru, Takata, Shinichi, Tanihara, Hidetoshi, Kamimura |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Methicillin-Resistant Staphylococcus aureus
medicine.medical_specialty Time Factors medicine.drug_class Antibiotics Pharmaceutical Science Erythromycin Minocycline Levofloxacin Fosfomycin medicine.disease_cause Hospitals University Japan Internal medicine Drug Resistance Bacterial Outpatients medicine Humans Pharmacology Inpatients business.industry Clindamycin biochemical phenomena metabolism and nutrition Antimicrobial Methicillin-resistant Staphylococcus aureus Anti-Bacterial Agents Gentamicins business medicine.drug |
| Zdroj: | YAKUGAKU ZASSHI. 134:269-276 |
| ISSN: | 1347-5231 0031-6903 |
| Popis: | The aim of this study was to investigate the trends and antimicrobial susceptibilities of methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from outpatients and inpatients from April 2008 to March 2013 at Fukuoka University Chikushi Hospital. The proportion of MRSA among the S. aureus isolates from outpatients was stable over the study period, however, that from inpatients gradually decreased (p=0.026). There was no difference in the susceptibility to anti-MRSA agents between MRSA isolates from outpatients and inpatients, however, the susceptibilities to fosfomycin (FOM), minocycline (MINO), levofloxacin, erythromycin and clindamycin were higher in MRSA isolates from outpatients than from inpatients (48.6% vs. 35.6%, 56.1% vs. 40.1%, 38.2% vs. 4.9%, 16.2% vs. 3.9% and 18.5% vs. 4.5%, respectively, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|